▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Reviews
——————————-
Association between Periodontal Disease and Arteriosclerosis-Related Diseases
Misaki Iwashita, J Atheroscler Thromb, 2023; 30: 1517-1524.
Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
Takahito Doi, et al., J Atheroscler Thromb, 2023; 30: 1525-1546.
——————————
Editorials
——————————-
Which Components of Fine Particulate Matter Have Adverse Vascular Health?
Takehiro Michikawa, J Atheroscler Thromb, 2023; 30: 1547-1548.
Time to Shift our Mindset to a Phosphate-Centric Approach for Prevention of Cardiovascular Calcification in the Dialysis Population
Shunsuke Yamada and Toshiaki Nakano, J Atheroscler Thromb, 2023; 30: 1549-1551.
——————————
Original Articles
——————————
Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China
Lijin Lin, et al., J Atheroscler Thromb, 2023; 30: 1552-1567.
Clinical Implication of Consistently Strict Phosphate Control for Coronary and Valvular Calcification in Incident Patients Undergoing Hemodialysis
Mao Shimizu, et al., J Atheroscler Thromb, 2023; 30: 1568-1579.
Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
Kenichi Tsujita, et al., J Atheroscler Thromb, 2023; 30: 1580-1600.
Validation of the Pulmonary Embolism Severity Index Risk Classification and the 2019 European Society of Cardiology Risk Stratification in the Southeast Asian Population with Acute Pulmonary Embolism
Chaiwat Bumroongkit, et al., J Atheroscler Thromb, 2023; 30: 1601-1611.
Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease
Masashi Yokoi, et al., J Atheroscler Thromb, 2023; 30: 1612-1621.
Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan
Hironobu Mitani, et al., J Atheroscler Thromb, 2023; 30: 1622-1634.
Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease
Kotaro Tokuda, et al., J Atheroscler Thromb, 2023; 30: 1635-1643.
Association between Intermediate-Density Lipoprotein Particles and the Progression of Carotid Atherosclerosis: A Community-Based Cohort Study
Tianxiao Liu, et al., J Atheroscler Thromb, 2023; 30: 1644-1660.
Histopathological Evaluation of Pulmonary Thromboendarterectomy Specimens of Chronic Thromboembolic Pulmonary Hypertension
Hiyo Obikane, et al., J Atheroscler Thromb, 2023; 30: 1661-1673.
Association between High Bleeding Risk and 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia
Naoki Yoshioka, et al., J Atheroscler Thromb, 2023; 30: 1674-1686.
Association between Eicosapentaenoic Acid to Arachidonic Acid Ratio and Characteristics of Plaque Rupture
Teruo Sekimoto, et al., J Atheroscler Thromb, 2023; 30: 1687-1702.
Persistent High Pulse Pressure in Acute Non-Cardiogenic Ischemic Stroke as a Predictor of Neurological Deterioration and Recurrence of Ischemic Stroke: ADS Post-Hoc Analysis
Tadashi Ozawa, et al., J Atheroscler Thromb, 2023; 30: 1703-1714.
Cholesterol Crystals as the Main Trigger of Interleukin-6 Production through Innate Inflammatory Response in Human Spontaneously Ruptured Aortic Plaques
Sei Komatsu, et al., J Atheroscler Thromb, 2023; 30: 1715-1726.
Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis
Shiho Masuda, et al., J Atheroscler Thromb, 2023; 30: 1727-1741.
The Novel Biomarkers-Based HALP (Hemoglobin, Albumin, Lymphocyte and Platelet)-Prognostic Model for Acute and Subacute Patients with Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study
Shen Li, et al., J Atheroscler Thromb, 2023; 30: 1742-1749.
——————————
Erratum
——————————
Effect of a Community-Based Program to Accelerate Referral to Physicians for Individuals at High-Risk of Lifestyle-Related Diseases: A Cluster Randomized Trial
Hiroyasu Iso, et al., J Atheroscler Thromb, 2023; 30: 1750.
2023/11/1